The study group | Without stimuli [pg/ml] | LPS ratioa
| Zymosan | CL097 |
---|
ASD-ISc
| Â | Â | Â | Â |
- Flare | 848.6 ± 344.8 | 1.48 ± 0.88b
| 1.15 ± 0.43b
| 0.55 ± 0.632
|
- Non-Flare | 648.7 ± 382.1 | 2.64 ± 1.37 | 2.15 ± 1.09 | 1.23 ± 1.12 |
ASD/NFA | 812.4 ± 365.5 | 1.96 ± 0.91 | 1.55 ± 0.75 | 0.89 ± 0.72 |
ASD/non-NFA | 855.4 ± 364.7 | 1.93 ± 1.12 | 1.63 ± 1.03 | 0.93 ± 0.91 |
Non-ASD/NFA | 948.5 ± 362.7 | 1.93 ± 1.38 | 1.66 ± 1.67 | 0.67 ± 0.51 |
Normal control | 677.7 ± 290.0 | 2.40 ± 1.10 | 1.93 ± 1.06 | 0.76 ± 0.69 |
PANS | Â | Â | Â | Â |
- Flare | 791.7 ± 449.4 | 1.87 ± 0.95 | 1.82 ± 1.27 | 1.38 ± 0.99 |
- Non-Flare | 945.8 ± 455.4 | 1.93 ± 1.14 | 1.66 ± 0.84 | 1.58 ± 1.07 |
-
aIL-10 production in response to LPS, zymosan, and CL097 were expressed as a ratio of IL-10 produced in these stimulants/IL-10 produced in the absence of stimuli. It should be noted that IL-10 production tends to be lower in the presence of CL097 in most of the study groups.
-
bIL-10 production by `flare’ ASD-IS cells were lower than `non-flare’ ASD-IS cells with matched pair analysis as detailed in Figure IL-10 production by `flare’ ASD-IS cells in response to LPS and zymosan were also lower than ASD/NFA and normal control cells (P <0.01). IL-10 production by `flare’ ASD-IS cells in response to CL097 cells were also lower than those produced by PANS cells (P <0.01).
-
c
Abbreviations used; ASD, autism spectrum disorder; ASD-IS, ASD-inflammatory subtype; IL, interleukin; LPS, lipopolysaccharide; NFA, non-IgE mediated food allergy; PANS, pediatric acute-onset neuropsychiatric syndrome.